Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Matrix completes patient enrollment in pivotal head and neck cancer trials

Jan. 17, 2000

Nippon Kayaku devotes significant resources to the fight against cancer

Jan. 17, 2000

Porphyrin-based agents for PDT and MRI designed at Schering AG

Jan. 17, 2000

Kinase-inhibitory antiproliferative indolones in development at Boehringer Ingelheim

Jan. 17, 2000

Mechanism of MDR reversal by TER-199 under investigation

Jan. 14, 2000

Access files IND for amlexanox oral rinse

Jan. 14, 2000

ImClone Systems achieves milestone in IMC-C225 collaboration with Merck KGaA

Jan. 13, 2000

Cephalon's CEP-701 enters phase II trials in prostate cancer

Jan. 13, 2000

FDA to review Aptosyn NDA without ODAC input

Jan. 13, 2000

GnRH-based fusion toxin markedly reduces human colon tumor growth in mouse model

Jan. 12, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...